Beijing Anzhen Hospital

This study looked at whether using a person's genetic information to choose their blood thinner medication after getting a heart stent can reduce the risk of heart attacks, strokes, and death. About 4,000 people with heart disease were given either clopidogrel or ticagrelor based…

This study is looking at whether an artificial intelligence tool can help doctors decide which heart surgery patients might benefit from a drug called ulinastatin. Ulinastatin is used to reduce inflammation after surgery, but it doesn't work for everyone. Researchers will analyze…

This study is testing a new AI-powered decision support system designed to help doctors diagnose and treat acute myocardial infarction (heart attack) more quickly and effectively. The system aims to address common delays in care, such as slow diagnosis in clinics and low complian…